Thermo Fisher Scientific (TMO) Price to Sales (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Price to Sales for 18 consecutive years, with 15.82 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 11.35% year-over-year to 15.82; the trailing twelve-month figure through Jun 2026 stood at 4.09 (up 14.74% YoY), and the FY2025 full-year result was 4.83, up 5.55% from the prior year.
• Price to Sales slipped to 15.82 in Q2 2026 per TMO's latest filing, from 15.98 in the prior quarter.
• Across five years, Price to Sales topped out at 22.18 in Q3 2024 and bottomed at 14.2 in Q2 2025.
• Historically, Price to Sales has averaged 18.41 across 5 years, with a median of 18.56 in 2022.
• The sharpest annual moves came in 2024 and 2025: Price to Sales advanced 19.9% in 2024, then slipped 29.28% in 2025.
• Over 5 years, Price to Sales stood at 18.54 in 2022, then advanced by 0.3% to 18.59 in 2023, then decreased by 7.36% to 17.22 in 2024, then grew by 2.32% to 17.62 in 2025, then slipped by 10.25% to 15.82 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 15.82, 15.98, and 17.62 for Q2 2026, Q1 2026, and Q4 2025 respectively.